Skip to main content
OpenTrials
Completed

NCT Number: NCT01651611

Intervention Study to Increase Smoking Cessation Rates Among Public Housing Residents

The purpose of this study is to determine whether public housing residents trained in Tobacco Cessation and Motivational Interviewing Techniques to become Tobacco Treatment Advocates(TTA) will be effective in increasing the quit rate of smokers in Boston Public Housing. The investigators hypothesize that smokers that receive multiple TTA visits will be more likely to (1) use smoking cessation resources and (2) quit compared to smokers who receive a single visit.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–79 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Boston University School of Public Health

Boston, Massachusetts, 02118, United States

About this study

The study is a group-randomized trial in which 10 pubic housing developments (PHDs) are randomized to the experimental condition and 10 to the control condition. All smokers who enroll in the study at a particular PHD receive the same intervention. Smokers at control sites receive written materials that offer strategies for quitting and information about availability of treatment programs, as well as a one-time meeting with a Tobacco Treatment Advocate (TTA). The intervention group receives the same written materials but also has much more extensive interactions with a TTA. TTAs provide peer counseling (Peer Counseling is defined as: performance of limited counselor functions, under counselor supervision, by person of similar age,gender, race, ethnicity and/or SES of the counselee) to smokers during in- person Motivational Enhancement meetings (target range 7-9) as well as additional in person and phone contacts, as needed for each participant, over a 6-month period. TTAs receive intensive training in motivational interviewing and smoking cessation counseling deliver the intervention components (counseling activities and provision of environmental supports) in addition to encouraging utilization of smoking cessation treatment programs such as the Smokers' QuitLine (SQL) and clinic-based programs. In order to avoid the potential for contamination due to TTAs interacting with participants at both intervention and control sites, meetings with participants at control sites are conducted by special Control TTAs. Data are collected from study participants at baseline, 3 months, 7 months and 12 months, and also from the SQL and clinics.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Current smoker, defined as having smoked in last 100days
  • Housing Sites: Sites are eligible for the study if they have 50+ smokers determined by synthetic estimates based on citywide survey data.
  • Age 18-79
  • Current everyday or someday smokers
  • Planning to quit smoking in 30 days or thinking about quitting in next 6 months,
  • Have smoked 100 cigarettes in lifetime
  • Speak English or Spanish
  • Plan to live in Public Housing for next 12 months
  • Able and willing to provide consent

Exclusion criteria

  • Smokers less than 18 years of age at time of consent.
  • Unable to communicate orally in English or Spanish.
  • Currently using pharmacological treatment for smoking cessation
  • Currently working with the Smokers Quitline or other Community Health Center based cessation program
  • Cognitive/ psychiatric conditions that would interfere with ability to understand and participate in the study
  • Have been abstinent for 7 or more days.

Treatment and study plan

Motivational Interviewing

Behavioral

The TTA will use motivational interviewing (MI) techniques to assess the participant's motivation and readiness to quit, suggest plans, and assist the participant in selecting a method of treatment.

Smoking Cessation Counseling

Behavioral

The TTA will provide information to the participant regarding evidence-based treatments for smoking cessation, including counseling and nicotine replacement therapy (NRT); assist in a quit plan; and discuss issues such as obtaining social support, staying in treatment, and dealing with lapses.

Navigation to smoking cessation resources

Behavioral

The TTA will assist participants in obtaining NRT and getting connected to smoking cessation counseling services, such as the Smokers' Quitline and clinic-based programs.

Social Support

Behavioral

Meetings with the TTA will be a source of social support for the participant as they attempt to quit or stay quit.

Primary outcomes

  1. Point prevalence smoking abstinence

    Time frame: 7 months

    7 and 30-day abstinence from smoking by self-report with verification by carbon monoxide breath test

Secondary outcomes

  1. Utilization of smoking cessation resources

    Time frame: 7 months

    Use of SQL, smoking cessation programs at health clinics or hospitals, physician counseling

Other outcomes

  1. Medication use

    Time frame: 3 months, 7 months, 12 months

    Use of nicotine replacement therapy and/or other smoking cessation medications

Sponsors and collaborators

Lead sponsor

Boston University

Other

Collaborators

  • Boston Housing Authority
  • Harvard School of Public Health (HSPH)
  • The Miriam Hospital

Registry information

Official study title

Health Advocates as a Vehicle to Improve Treatment for Smokers in Public Housing

Important dates

Study start
2011
Primary completion
2014
Study completion
2014
First posted
Jul 27, 2012
Registry last updated
Aug 29, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.